Library       Monographs Monographs with relevance to animal cell technology are available here. What is Animal Cell Technology Beneficial Effects of Animal Cell Technology Biotechnology and biopharmaceuticals The what and why of patents in biotechnology Safety testing of Biotechnology Products derived from Cell Lines of Human and Animal Origin Past, present and future of monoclonal antibodies Vaccines Gene therapy Transmissable Spongiform Encephalopaties: The what and how of TSEs     Actip news bulletins The following ACTIP bulletins are still available: Bulletin 12 Bulletin 13 Bulletin 14 Bulletin 15 Bulletin 16 Bulletin 17 Bulletin 18 Bulletin 19 Bulletin 20 Bulletin 21 Bulletin 22 Bulletin 23 Bulletin 24 Bulletin 25 Bulletin 26 Bulletin 27 Bulletin 28 Bulletin 29 Bulletin 30 Bulletin 31 Bulletin 32 Bulletin 33 Bulletin 34 Bulletin 35 Bulletin 36 Bulletin 37 Bulletin 38 Bulletin 39 Bulletin 40 Bulletin 41 Bulletin 42 Bulletin 43 Bulletin 44 Bulletin 45 Bulletin 46 Bulletin 47 Bulletin 48 Bulletin 49 Bulletin 50 Bulletin 51       Actip position papers Over the years, ACTIP has published various position papers, wich you can read/download by clicking on the title. Actip Position paper on future areas of research to be funded A proposal for funding by the European Union of research in the field of animal cell technology and related areas, to be incorporated into the 6th Framework Programme The what and why of patents in biotechnology Statement on gene therapy ACTIP's position paper on TSE Economic importance Biotechnology       Commission documents ACTIP maintains good relationships with the European Commission. The following EC documents are available in this library: The Fifth Framework programme 1998 - 2002 Official Journal of the European Commission News from the Commission August 2000 News from the Commission September 1999       Regulatory documents Regularly, ACTIP makes links to documents of regulatory authorities. The following are available: EC Document 'A guideline on dossier requirements for Type 1 variations' Preliminary report - 'the evaluation of tests for the diagnosis of transmissable spongiform encephalopathy in bovines' FDA draft Guidance for industry 'supplemental guidance on testing for replication competent retrovirus in gene therapy and follow up of patients' FDA Guidance for industry 'application of current statutory authority to nucleic acid testing of pooled plasma' FDA Revised Guidance for industry on 'revised precautionary methods to reduce the possible risk of transmission of CJD and nvCJD by blood and blood products' Back To Top | Home | Objectives |  Organization | Members | News and Info  | Publications | Products | Interesting Links | Secure |  Contact Us © 2008 ACTIP